Market Overview

Why Kodiak Sciences Stock Is Trading Lower Today


Kodiak Sciences (NASDAQ: KOD) shares are trading lower after BMO Capital downgraded the stock from Outperform to Market Perform.

Kodiak Sciences is a clinical stage company. It is engaged in developing innovative therapeutics to treat high prevalence of ophthalmic diseases. The most advanced product candidate of the group is KSI-301, a biologic therapy built with antibody biopolymer conjugate platform, which is designed to maintain potent and effective drug levels in ocular tissue.

Kodiak Sciences shares traded down 4.60% to $156.78 The stock has a 52-week high of $169.98 and a 52-week low of $35.49.


Related Articles (KOD)

View Comments and Join the Discussion!

Posted-In: why it's movingNews

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at